A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.
A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...
Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...
Morning Overview on MSN
Trial: Sulthiame pill cut sleep apnea breathing interruptions by 50%
A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...
ScienceAlert on MSN
Repurposed Drug Improves Sleep Apnea by Up to 50% in Clinical Trial
(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more comfortable alternative is on the horizon. In a recent clinical drug trial that ...
A potential sleep apnea pill, heart-healthy habits for kids, and the surprising mental health effects of March Madness — here ...
Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...
Right-size your expectations.
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...
If you hate putting on the CPAP mask each night to help increase your breathing intake and to get a good night’s sleep, you may be in luck. A recent clinical trial found that a certain drug ...
For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.
Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results